Yoshino T, Oki E, Misumi T, Kotaka M, et al. Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial. J Clin Oncol 2022 May 5:JCO2102628. doi: 10.1200/JCO.21.02628.
PMID: 35512259